Evidence map›Paper›PMID 28463106›Full record

ArticleeLife2017

Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus.

Yongwang Zhong, Jiou Wang, Mark J Henderson, Peixin Yang, Brian M Hagen, Teepu Siddique, Bruce E Vogel, Han-Xiang Deng, Shengyun Fang

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Karyopherin-mediated nucleocytoplasmic transport.Nature reviews. Molecular cell biology · 2022
    Review
  15. Genes · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yongwang ZhongCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, United States.
Jiou WangDepartment of Biochemistry and Molecular Biology, Johns Hopkins University, Baltimore, United States.
Mark J HendersonNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, United States.
Peixin YangDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, United States.
Brian M HagenCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, United States.
Teepu SiddiqueDivision of Neuromuscular Medicine, Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, United States.
Bruce E VogelCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, United States.
Han-Xiang DengDivision of Neuromuscular Medicine, Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, United States.
Shengyun FangCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, United States.ORCID 0000-0001-7280-5463
University of Maryland, Baltimore · USNorthwestern University · USJohns Hopkins University · USNational Institutes of Health · US

Funding

Neurodegeneration and Proteotoxicity Dissected in C. elegans and MammalsR01NS074324 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIOU · 2011 to 2025
$6.2M
High-Content Screening to Identify Small Molecules for Refolding SOD1 MutantsU01GM117175 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI FANG, SHENGYUN · 2017 to 2019
$1.1M
Chemical chaperones for refolding mutant SOD1ZIATR000319 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI SIMEONOV, ANTON · 2017 to 2021
$694k
NIGMS NIH HHS U01 GM117175NINDS NIH HHS R01 NS074324
6 · The paper itself

Abstract

Over 170 different mutations in the gene encoding SOD1 all cause amyotrophic lateral sclerosis (ALS). Available studies have been primarily focused on the mechanisms underlying mutant SOD1 cytotoxicity. How cells defend against the cytotoxicity remains largely unknown. Here, we show that misfolding of ALS-linked SOD1 mutants and wild-type (wt) SOD1 exposes a normally buried nuclear export signal (NES)-like sequence. The nuclear export carrier protein CRM1 recognizes this NES-like sequence and exports misfolded SOD1 to the cytoplasm. Antibodies against the NES-like sequence recognize misfolded SOD1, but not native wt SOD1 both in vitro and in vivo. Disruption of the NES consensus sequence relocalizes mutant SOD1 to the nucleus, resulting in higher toxicity in cells, and severer impairments in locomotion, egg-laying, and survival in

Indexed as

Active Transport, Cell NucleusProtein FoldingAmino Acid MotifsAnimalsCaenorhabditis elegansExportin 1 ProteinKaryopherinsMutant ProteinsProtein BindingProtein Sorting SignalsReceptors, Cytoplasmic and NuclearSuperoxide Dismutase-1Exportin 1 ProteinKaryopherinsMutant ProteinsProtein Sorting SignalsReceptors, Cytoplasmic and NuclearSuperoxide Dismutase-1ALSC. eleganscell biologycytotoxicitynuclear export signalprotein misfoldingSOD1

Identifiers

PMID28463106
PMCPMC5449186
OpenAlexW2611497617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.